203 related articles for article (PubMed ID: 11821796)
1. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development.
Akagi K; Ikeda Y; Sumiyoshi Y; Kimura Y; Kinoshita J; Miyazaki M; Abe T
Surgery; 2002 Jan; 131(1 Suppl):S109-13. PubMed ID: 11821796
[TBL] [Abstract][Full Text] [Related]
2. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
5. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.
Pruneri G; Ponzoni M; Ferreri AJ; Decarli N; Tresoldi M; Raggi F; Baldessari C; Freschi M; Baldini L; Goldaniga M; Neri A; Carboni N; Bertolini F; Viale G
Br J Haematol; 2002 Sep; 118(3):817-20. PubMed ID: 12181051
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
9. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
11. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer.
Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C
Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208
[TBL] [Abstract][Full Text] [Related]
14. Interaction between morphology and angiogenesis in human early colorectal cancers.
Okada K; Satoh T; Fujimoto K; Tokunaga O
Pathol Int; 2004 Jul; 54(7):490-7. PubMed ID: 15189502
[TBL] [Abstract][Full Text] [Related]
15. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
[TBL] [Abstract][Full Text] [Related]
16. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
Kumar S; Ghellal A; Li C; Byrne G; Haboubi N; Wang JM; Bundred N
Cancer Res; 1999 Feb; 59(4):856-61. PubMed ID: 10029075
[TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
19. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
[TBL] [Abstract][Full Text] [Related]
20. Comparison of blood neoangiogenesis and lymphatic vascularization in colorectal adenomas from patients with and without concomitant colorectal cancer.
Moreira LR; Schenka AA; Filho PL; Lima CS; Trevisan MA; Vassallo J
Braz J Med Biol Res; 2009 Jul; 42(7):593-8. PubMed ID: 19466284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]